Covid fatigue takes toll on vaccine makers
Demand for boosters falls as virus seen as something less to be feared than managed
Investing. Plain and simple.
Demand for boosters falls as virus seen as something less to be feared than managed
With its shares down 93% since its IPO, the telehealth company may try a tactic which doesn’t usually work.
Considered dull during the tech boom, these mature, global businesses are back in favour.
UK-based firm has lost more than half of its value since its October IPO which raised money for US expansion.
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
It should be another good year, but share prices may have limited upside.
The healthcare sector offers safety and stability because the companies tend to perform well in all economic conditions.
IPOs carry higher risk, but this healthcare company has Telus and the UK National Health Service as clients.
Millennials are the largest pet-owning cohort and treating their pets like children.
Some stocks that made big lockdown gains have sold off as economies reopen.
You must be logged in to post a comment.